story of the week
Outcome of Melanoma Patients With Elevated LDH Treated With First-Line Targeted Therapy or PD-1–Based Immune Checkpoint Inhibition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outcome of Melanoma Patients With Elevated LDH Treated With First-Line Targeted Therapy or PD-1-Based Immune Checkpoint Inhibition
Eur. J. Cancer 2021 May 01;148(xx)61-75, S Knispel, M Gassenmaier, AM Menzies, C Loquai, DB Johnson, C Franklin, R Gutzmer, JC Hassel, C Weishaupt, T Eigentler, B Schilling, P Schummer, J Sirokay, F Kiecker, CN Owen, MI Fleischer, C Cann, KC Kähler, P Mohr, L Bluhm, D Niebel, KM Thoms, SM Goldinger, L Reinhardt, F Meier, C Berking, R Reinhard, L Susok, PA Ascierto, K Drexler, C Pföhler, J Tietze, L Heinzerling, E Livingstone, S Ugurel, GV Long, A Stang, D Schadendorf, L ZimmerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.